Home » Newsletters » BioWorld Science

BioWorld Science

April 8, 1997

View Archived Issues

Recordati announces 1996 consolidated results

LifeTECH Corp. reports results for fiscal year 1996 and first quarter 1997

Cel-Sci six-month clinical update

EntreMed reports fiscal 1996 year-end results and receives U.S. patent

Biomira announces fourth-quarter and 1996 results

Imutec Pharma announces third-quarter results

Ribozyme Pharmaceuticals reports fourth-quarter and year-end financial results

Interferon Sciences reports 1996 operating results and clinical status update

OXIS International reports fiscal year-end results

Aquila Biopharmaceuticals reports fourth-quarter and 1996 year-end financial results

Cobalt porphyrins for obesity from Warner-Lambert

Novel antiemetic reported by Dainippon

Mitsubishi Chemical describes thrombin inhibitors

PGE2 agonists/antagonists from Ono

T-686 inhibits PAI-1 and development of atherosclerotic lesions

Inogatran exerts selective inhibition of thrombin in vitro

Taiho claims nitroimidazoles with antiangiogenic and contrast-enhancing effects

Chronic MK-677 increases GH and IGF-I in dogs

Clinical comparison of cromolyn and furosemide in asthmatics

Gene Logic/Johns Hopkins collaborate on schizophrenia and depression gene discovery

Eagle licenses biotin technology from University of Washington

Genes involved in marijuana abuse

Human skin equivalent approved in Canada

Component of olive oil demonstrates antioxidant and lipoxygenase-inhibitory effects

Hybridon receives clearance to initiate further GEM-132 trials

PEG-rHuMGDF safe and effective for chemotherapy-induced thrombocytopenia

Nigella sativa plant extract exerts antiangiogenic activity

Triangle Pharmaceuticals exercises option to acquire MKC-442

RPR's Tilade approved for pediatric use

Pharmacia & Upjohn's Rescriptor cleared by FDA

Connetics commences phase III trial for betamethasone mousse

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...